Merger: absorbed by CYNARA
Dissolution of the company · Dissolved without liquidation · Books and records kept by CYNARA in Brussels (5 years) · Gazette deed
Merger proposal: to be absorbed by CYNARA
Gazette deed
Director in office: Hidden nameVisible after signing in (manager)
Gazette deed
Incorporation
Founded by Name after signing inVisible after signing in · Founding capital of €18,600, 186 shares, €12,400 paid up · Name hiddenVisible after signing in appointed as manager · Gazette deed
Absorbed by CYNARA in October 2013. The last annual accounts are for financial year 2012. The company was dissolved without liquidation. The books and records are kept for 5 years by CYNARA in Brussels.
The turnover in financial year 2012 is ≈ €130,000. This figure is estimated from the gross margin of €35,914 and 889 comparable companies of the same size. It probably lies between €69,000 and €260,000. It is a rough estimate.Financials
Is EUROPHARMA profitable?
In financial year 2012, EUROPHARMA made a loss of €6,285.
Where can I find the annual accounts of EUROPHARMA?
EUROPHARMA filed 1 annual account with the National Bank of Belgium, for financial year 2012.